๐ฐ Leukemia News
Page 84 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
December 14, 2023
Studies found new evidence that living near oil and gas extraction sites is hazardous to human health.
December 13, 2023
Each year, approximately 60,000 people in the U.S. will be diagnosed with leukemia. While there is technically no cure – the best shot of something close comes with a stem
December 13, 2023
In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
December 13, 2023
Recently approved by the FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), Jaypirca โrepresents a meaningful advanceโ in treatment, as one expert explained.
December 12, 2023
Non-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine's Abramson Cancer Center at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition.
December 12, 2023
Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase III trial has found.
December 12, 2023
Revumenib demonstrated clinically meaningful activity, including high response and minimal residual disease negativity rates, in heavily pretreated patients with KMT2A-rearranged acute leukemia.
December 12, 2023
Ibrahim T. Aldoss, MD, of City of Hope Comprehensive Cancer Center, discusses the potential of revumenib in KMT2A-rearranged (KMT2Ar) acute leukemias, with pivotal results presented at the 65th Annual American Society of Hematology Annual Meeting and Exposition this week.
December 12, 2023
Children and adults with relapsed/refractory KMT2A rearranged acute leukemia may obtain promising response rates with revumenib, a novel targeted therapy.
December 12, 2023
A novel cell therapy demonstrated early efficacy and an acceptable safety profile in patients with graft-versus-host disease undergoing haploidentical stem cell transplantation.